Metabolism


Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
C3266 Amino TadalafilSummary: analog of tadalafil, a potent inhibitor of phosphodiesterase 5 -
C3328 DL-α-Difluoromethylornithine (hydrochloride hydrate)Summary: ornithine decarboxylase inhibitor, irreversible -
C3034 1-Deoxygalactonojirimycin (hydrochloride)Summary: α-galactosidase inhibitor -
C3364 7-hydroxycoumarinyl ArachidonateSummary: substrate for cPLA2 -
C3091 11-keto-β-Boswellic AcidSummary: leukotriene synthesis inhibitor via 5-lipoxygenase -
C3463 BCATc Inhibitor 2Summary: cytosolic BCAT (BCATc) inhibitor -
C3414 (S)-MephenytoinSummary: substrate of the cytochrome P450 (CYP) isoform CYP2C19 -
C3407 GQ-16Summary: partial agonist for PPARγ -
C3471 Omeprazole sulfoneSummary: CYP2C19 inhibitor -
B7840 Lin28 1632Summary: RNA binding protein Lin28 inhibitor, also bromodomain inhibitor
